Mainstream

Adaptive Biotechnologies targets $1,300 ASP for MRD tests in 2025 driven by pricing improvements

Adaptive Biotechnologies targets $1,300 ASP for MRD tests in 2025 driven by pricing improvements

Post ContentadptRead More

You might also be interested in reading Indonesia Picks Crypto-Friendly Team in Presidential Election.

February 12, 2025
In Mainstream